Traditional Roles in a Non‐Traditional Setting: Genetic Counseling in Precision Oncology

Abstract

Next generation sequencing technology is increasingly utilized in oncology with the goal of targeting therapeutics to improve response and reduce side effects. Interpretation of tumor mutations requires sequencing of paired germline DNA, raising questions about incidental germline findings. We describe our experiences as part of a research team implementing a protocol for whole genome sequencing (WGS) of tumors and paired germline DNA known as the Michigan Oncology Sequencing project (MI-ONCOSEQ) that includes options for receiving incidental germline findings. Genetic counselors (GCs) discuss options for return of results with patients during the informed consent process and document family histories. GCs also review germline findings and actively participate in the multi-disciplinary Precision Medicine Tumor Board (PMTB), providing clinical context for interpretation of germline results and making recommendations about disclosure of germline findings. GCs have encountered ethical and counseling challenges with participants, described here. Although GCs have not been traditionally involved in molecular testing of tumors, our experiences with MI-ONCOSEQ demonstrate that GCs have important applicable skills to contribute to multi-disciplinary care teams implementing precision oncology. Broader use of WGS in oncology treatment decision making and American College of Medical Genetics and Genomics (ACMG) recommendations for active interrogation of germline tissue in tumor-normal dyads suggests that GCs will have future opportunities in this area outside of research settings.

“A rising tide lifts all boats”: establishing a multidisciplinary genomic tumor board for breast cancer patients with advanced disease

“…This may be especially important if the MGTB is to avoid overreliance on the commercial laboratory’s interpretation of genomic test results, a concern raised both by physician-scientists and basic scientists who noted the group’s relatively uncritical acceptance of the validity of (FoundationOne TM ) results. Participants also noted benefits of increasing the participation of professionals who may be particularly useful for securing informed consent for genomic testing, managing incidental germline findings, and serving as educational resources for MGTB members [32]. …”

Impact of a Prospective Review Program for Reference Laboratory Testing Requests

“…In addition, making a designated "reference testing" genetic counselor available to clinicians both at the time of ordering and at the time a report is available may be a means to provide consultative assistance throughout the reference testing process. 20,21 …”

A review of drugs in development for the personalized treatment of head and neck squamous cell carcinoma

“…Involvement of genetic counselors will be invaluable in relaying and interpreting findings (primary, incidental and secondary) and managing expectations. Indeed, inclusion of genetic counselors is becoming an equally important part of the oncology team and Precision Medicine Tumor Board in centers implementing genomically based personalized oncology paradigms [63]. …”